These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3236731)

  • 1. [Tear substitutes. Experimental and clinical observations].
    Brewitt H
    Klin Monbl Augenheilkd; 1988 Sep; 193(3):275-82. PubMed ID: 3236731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of tear substitutes and their immediate effect on the precorneal tear film.
    Avisar R; Creter D; Levinsky H; Savir H
    Isr J Med Sci; 1997 Mar; 33(3):194-7. PubMed ID: 9313790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study of treatment of the dry eye syndrome due to disturbances of the tear film lipid layer with lipid-containing tear substitutes].
    Dausch D; Lee S; Dausch S; Kim JC; Schwert G; Michelson W
    Klin Monbl Augenheilkd; 2006 Dec; 223(12):974-83. PubMed ID: 17199193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro alteration of Schirmer's tear strip wetting by commonly instilled anesthetic agents.
    Hodkin MJ; Cartwright MJ; Kurumety UR
    Cornea; 1994 Mar; 13(2):141-7. PubMed ID: 8156786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical properties of stimulated and unstimulated tears.
    Pandit JC; Nagyová B; Bron AJ; Tiffany JM
    Exp Eye Res; 1999 Feb; 68(2):247-53. PubMed ID: 10068490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Scanning electron microscopy studies of the effectiveness of artificial tears].
    Brewitt H; Joost P
    Fortschr Ophthalmol; 1987; 84(2):150-4. PubMed ID: 3596412
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical performance of a mid-viscosity artificial tear for dry eye treatment.
    Simmons PA; Vehige JG
    Cornea; 2007 Apr; 26(3):294-302. PubMed ID: 17413956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of ocular dryness with soluble implants].
    Arrata M; Sfeir T
    Bull Mem Soc Fr Ophtalmol; 1980; 92():134-8. PubMed ID: 7225671
    [No Abstract]   [Full Text] [Related]  

  • 9. The instilled fluid dynamics and surface chemistry of polymers in the preocular tear film.
    Benedetto DA; Shah DO; Kaufman HE
    Invest Ophthalmol; 1975 Dec; 14(12):887-902. PubMed ID: 1104516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Corneal contact time of artificial tear solutions].
    Marquardt R; Christ T
    Klin Monbl Augenheilkd; 1986 Sep; 189(3):254-7. PubMed ID: 3784417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eye parameters for the diagnosis of xerophthalmos.
    Murube-del-Castillo J; Cortes-Rodrigo MD
    Clin Exp Rheumatol; 1989; 7(2):145-50. PubMed ID: 2661074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations among ocular surface temperature difference value, the tear meniscus height, Schirmer's test and fluorescein tear film break up time.
    Su TY; Ho WT; Lu CY; Chang SW; Chiang HK
    Br J Ophthalmol; 2015 Apr; 99(4):482-7. PubMed ID: 25297654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness and tolerance of a polyvidon substance in treatment of dry eye syndromes].
    Otto S; Roth HW
    Klin Monbl Augenheilkd; 1996 Dec; 209(6):362-7. PubMed ID: 9091713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the Schirmer's test and orbital morphology in predicting dry-eye syndrome after blepharoplasty.
    Rees TD; LaTrenta GS
    Plast Reconstr Surg; 1988 Oct; 82(4):619-25. PubMed ID: 3420183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis and therapy of the dry eye].
    Scherz W
    Buch Augenarzt; 1978; (75):220-42. PubMed ID: 573162
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current treatments of xerophthalmia in Sjögren's syndrome].
    Baudouin C; Pisella PJ; Brignole F
    Rev Med Interne; 2004 May; 25(5):376-82. PubMed ID: 15110955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What's artificial in artificial tears?
    Kralian LM
    Am J Optom Physiol Opt; 1986 Apr; 63(4):304-8. PubMed ID: 3706489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyacrylic acid/polyvinylpyrrolidone bipolymeric systems. I. Rheological and mucoadhesive properties of formulations potentially useful for the treatment of dry-eye-syndrome.
    Oechsner M; Keipert S
    Eur J Pharm Biopharm; 1999 Mar; 47(2):113-8. PubMed ID: 10234534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of dry eye: an analysis of the British Sjögren's syndrome association comparing substitute tear viscosity and subjective efficacy.
    Bhojwani R; Cellesi F; Maino A; Jalil A; Haider D; Noble B
    Cont Lens Anterior Eye; 2011 Dec; 34(6):269-73. PubMed ID: 21689965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Taufon use in myopic contact lens wearers].
    Naumenko VV; Pogosian MA; Sergeev VP
    Vestn Oftalmol; 2014; 130(4):97-8, 100-1. PubMed ID: 25306731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.